Is Mustang Bio Inc (MBIO) overvalued? · $11.6M cap
Mustang Bio Inc (MBIO) is a biotechnology company listed on US.
This page asks whether Mustang Bio Inc (MBIO) looks expensive on cached numbers — not a short thesis.
No cached income statement for MBIO, so there is no earnings base to call rich or cheap.
MBIO currently screens at market cap $11.6M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next MBIO 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the MBIO stock page for the full model, not this heading.
Not investment advice.